Recent research focusing on Tirzepatide at a dosage of 20mg is shedding new light on its potential applications. Initial findings suggest that this higher dosage may amplify the drug's ability to control blood levels, potentially offering more significant outcomes for individuals with type 2 diabetes. Further research is underway to fully evaluate